2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures

HomeCirculation: Cardiovascular Quality and OutcomesAhead of Print2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures Free AccessReview ArticlePDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUB2024 ACC/AHA Clinical Performance and Quality Measures for Adults With Valvular and Structural Heart Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures Hani Jneid, Joanna Chikwe, Suzanne V. Arnold, Robert O. Bonow, Steven M. Bradley, Edward P. Chen, Rebecca L. Diekemper, Setri Fugar, Douglas R. Johnston, Dharam J. Kumbhani, Roxana Mehran, Arunima Misra, Manesh R. Patel, Ranya N. Sweis and Molly Szerlip Hani JneidHani Jneid , Joanna ChikweJoanna Chikwe , Suzanne V. ArnoldSuzanne V. Arnold , Robert O. BonowRobert O. Bonow , Steven M. BradleySteven M. Bradley , Edward P. ChenEdward P. Chen , Rebecca L. DiekemperRebecca L. Diekemper , Setri FugarSetri Fugar , Douglas R. JohnstonDouglas R. Johnston , Dharam J. KumbhaniDharam J. Kumbhani , Roxana MehranRoxana Mehran , Arunima MisraArunima Misra , Manesh R. PatelManesh R. Patel , Ranya N. SweisRanya N. Sweis and Molly SzerlipMolly Szerlip Originally published14 Mar 2024https://doi.org/10.1161/HCQ.0000000000000129Circulation: Cardiovascular Quality and Outcomes. 2024;0:e000129FootnotesDeveloped in Collaboration With the American Association for Thoracic Surgery and the Society for Cardiovascular Angiography and InterventionsEndorsed by the American Society of Echocardiography and the Heart Rhythm SocietyACC/AHA Joint Committee on Performance Measures, see page e•••.The American Heart Association requests that this document be cited as follows: Jneid H, Chikwe J, Arnold SV, Bonow RO, Bradley SM, Chen EP, Diekemper RL, Fugar S, Johnston DR, Kumbhani DJ, Mehran R, Misra A, Patel MR, Sweis RN, Szerlip M. 2024 ACC/AHA clinical performance and quality measures for adults with valvular and structural heart disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures. Circ Cardiovasc Qual Outcomes. 2024;17:e000129. doi: 10.1161/HCQ.0000000000000129The Measure is not a clinical practice guideline, does not establish a standard of medical care, and has not been tested for all potential applications.The Measure, although copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes (eg, use by health care professionals in connection with their practices). Commercial use is defined as the sale, license, or distribution of the Measure for commercial gain or incorporation of the Measure into a product or service that is sold, licensed, or distributed for commercial gain.Commercial uses of the Measure require a license agreement between the user and the American College of Cardiology (ACC) or the American Heart Association (AHA). The ACC, AHA, and their members shall not be responsible for any use of the Measure.The ACC and AHA encourage use of the Measure by other health care professionals, where appropriate.The Measure and specifications are provided "as is" without warranty of any kind.Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The ACC and AHA, and their members, disclaim all liability for use or accuracy of any Current Procedural Terminology or other coding contained in the specifications.This document underwent a 14-day peer review between April 12, 2023, and April 26, 2023, and a 30-day public comment period between April 12, 2023, and May 12, 2023.This document was approved by the American College of Cardiology Clinical Policy Approval Committee and the American Heart Association Science Advisory and Coordinating Committee in December 2023; and by the American College of Cardiology Science and Quality Committee, the American Heart Association Executive Committee, the American Association for Thoracic Surgery, and the Society for Cardiovascular Angiography and Interventions in January 2024. Previous Back to top Next FiguresReferencesRelatedDetails Advertisement Article InformationMetrics © 2024 American College of Cardiology Foundation and American Heart Association, Inc.freehttps://doi.org/10.1161/HCQ.0000000000000129PMID: 38484039 Originally publishedMarch 14, 2024 KeywordsAHA Scientific Statementsperformance measuresquality indicatorsquality measuresstructural heart diseasevalvular heart diseasePDF download Advertisement SubjectsStatements and Guidelines